$VRME
VerifyMe Inc Stock $vrme

$vrme Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121465923011000 Filed on August 10, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$5.604M	$5.335M
YoY Change	7.46%	18.63%
Cost Of Revenue	$3.312M	$3.515M
YoY Change	-1.43%	25.0%
Gross Profit	$2.292M	$1.820M
YoY Change	23.56%	8.01%
Gross Profit Margin	40.9%	34.11%
Selling, General & Admin	$3.142M	$2.848M
YoY Change	16.76%	-4.49%
% of Gross Profit	137.09%	156.48%
Research & Development	$5.000K	$10.00K
YoY Change	-87.18%	-60.0%
% of Gross Profit	0.22%	0.55%
Depreciation & Amortization	$300.0K	$258.0K
YoY Change	14.94%	6.17%
% of Gross Profit	13.09%	14.18%
Operating Expenses	$3.147M	$2.858M
YoY Change	15.27%	-4.96%
Operating Profit	-$855.0K	-$1.038M
YoY Change	-2.29%	-21.48%
Interest Expense	-$40.00K	-$16.00K
YoY Change	21.21%	-99.86%
% of Operating Profit
Other Income/Expense, Net	-$75.00K	$156.0K
YoY Change	-123.58%	-101.39%
Pretax Income	-$930.0K	-$882.0K
YoY Change	66.97%	-92.97%
Income Tax
% Of Pretax Income
Net Earnings	-$930.0K	-$882.0K
YoY Change	66.97%	-92.97%
Net Earnings / Revenue	-16.6%	-16.53%
Basic Earnings Per Share	-$0.09	-$0.09
Diluted Earnings Per Share	-$0.09	-$0.09
COMMON SHARES
Basic Shares Outstanding	9.900M shares	9.392M shares
Diluted Shares Outstanding	9.879M shares	9.765M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.010M	$2.697M
YoY Change	-20.52%	-29.86%
Cash & Equivalents	$2.944M	$2.697M
Short-Term Investments
Other Short-Term Assets	$300.0K	$308.0K
YoY Change	57.89%	31.62%
Inventory	$42.00K	$47.00K
Prepaid Expenses
Receivables	$1.379M	$1.286M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$5.615M	$5.072M
YoY Change	-6.43%	-21.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$265.0K	$288.0K
YoY Change	-17.45%	-17.95%
Goodwill	$5.313M	$5.338M
YoY Change	29.84%	30.45%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$182.0K
YoY Change		71.7%
Total Long-Term Assets	$13.19M	$13.35M
YoY Change	15.5%	15.13%
TOTAL ASSETS
Total Short-Term Assets	$5.615M	$5.072M
Total Long-Term Assets	$13.19M	$13.35M
Total Assets	$18.81M	$18.42M
YoY Change	7.94%	1.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.497M	$1.400M
YoY Change	22.7%	-0.43%
Accrued Expenses	$815.0K	$723.0K
YoY Change	67.7%	27.51%
Deferred Revenue
YoY Change
Short-Term Debt	$500.0K	$500.0K
YoY Change	0.0%	0.0%
Long-Term Debt Due	$1.000M	$1.300M
YoY Change	100.0%	160.0%
Total Short-Term Liabilities	$3.634M	$3.719M
YoY Change	56.5%	43.65%
LONG-TERM LIABILITIES
Long-Term Debt	$2.100M	$1.125M
YoY Change	40.0%	-25.0%
Other Long-Term Liabilities	$1.170M	$1.222M
YoY Change	202.33%	193.75%
Total Long-Term Liabilities	$3.270M	$2.347M
YoY Change	73.29%	22.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.634M	$3.719M
Total Long-Term Liabilities	$3.270M	$2.347M
Total Liabilities	$6.907M	$6.066M
YoY Change	64.1%	34.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$81.85M	-$80.92M
YoY Change	4.18%	3.73%
Common Stock	$10.00K	$10.00K
YoY Change	0.0%	11.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$748.0K	$792.0K
YoY Change	-11.27%	4.76%
Treasury Stock Shares
Shareholders Equity	$11.90M	$12.36M
YoY Change
Total Liabilities & Shareholders Equity	$18.81M	$18.42M
YoY Change	7.94%	1.82%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$930.0K	-$882.0K
YoY Change	66.97%	-92.97%
Depreciation, Depletion And Amortization	$300.0K	$258.0K
YoY Change	14.94%	6.17%
Cash From Operating Activities	-$140.0K	-$337.0K
YoY Change	225.58%	-79.25%
INVESTING ACTIVITIES
Capital Expenditures	$210.0K	$217.0K
YoY Change	-255.56%	-21800.0%
Acquisitions
YoY Change
Other Investing Activities	-$10.00K	-$20.00K
YoY Change	-152.63%	-99.74%
Cash From Investing Activities	-$220.0K	-$237.0K
YoY Change	89.66%	-96.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	670.0K	185.0K
YoY Change	556.86%	-95.93%
NET CHANGE
Cash From Operating Activities	-140.0K	-337.0K
Cash From Investing Activities	-220.0K	-237.0K
Cash From Financing Activities	670.0K	185.0K
Net Change In Cash	310.0K	-389.0K
YoY Change	-643.86%	-91.69%
FREE CASH FLOW
Cash From Operating Activities	-$140.0K	-$337.0K
Capital Expenditures	$210.0K	$217.0K
Free Cash Flow	-$350.0K	-$554.0K
YoY Change	-480.43%	-65.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2535000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5098000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	506000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	447000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1000000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001104038
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	vrme	Contingent Liability Current ContingentLiabilityCurrent		usd
CY2022Q4	vrme	Contingent Liability Non Current ContingentLiabilityNonCurrent		usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
CY2022Q2	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration		usd
	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration		usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022Q2	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap		usd
	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap		usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax		usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax		usd
	vrme	Gain Or Loss On Change In Fair Value Of Contingent Consideration GainOrLossOnChangeInFairValueOfContingentConsideration		usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets		usd
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition		usd
	us-gaap	Payments For Software PaymentsForSoftware		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity		usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	vrme	Noncash Change In Fair Value Of Interest Rate Swap NoncashChangeInFairValueOfInterestRateSwap		usd
	vrme	Initial Recognition Of Rightofuse Asset And Lease Liability During Period InitialRecognitionOfRightofuseAssetAndLeaseLiabilityDuringPeriod		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q2	vrme	Sharebased Compensation Arrangement By Sharebased Payment Award Other Than Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1		usd
CY2023Q2	vrme	Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39332
	dei	Entity Registrant Name EntityRegistrantName	VERIFYME, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	23-3023677
	dei	Entity Address Address Line1 EntityAddressAddressLine1	801 International Parkway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Fifth Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	Lake Mary
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32746
	dei	City Area Code CityAreaCode	(585)
	dei	Local Phone Number LocalPhoneNumber	736-9400
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9899767	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2697000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3411000	usd
CY2023Q2	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	33000	usd
CY2022Q4	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	37000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1286000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4448000	usd
CY2023Q2	vrme	Unbilled Revenue UnbilledRevenue	734000	usd
CY2022Q4	vrme	Unbilled Revenue UnbilledRevenue	1185000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	308000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	333000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	47000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	81000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	5072000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9458000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	288000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	292000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	554000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	469000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6990000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6412000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	5338000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	3988000	usd
CY2023Q2	us-gaap	Deferred Costs DeferredCosts	182000	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	133000	usd
CY2023Q2	us-gaap	Assets Assets	18424000	usd
CY2022Q4	us-gaap	Assets Assets	20752000	usd
CY2023Q2	us-gaap	Debt Current DebtCurrent	1300000	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	500000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1400000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3912000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	723000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	902000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	174000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115000	usd
CY2023Q2	vrme	Contingent Liability Current ContingentLiabilityCurrent	122000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3719000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5429000	usd
CY2023Q2	vrme	Contingent Liability Non Current ContingentLiabilityNonCurrent	831000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	389000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359000	usd
CY2023Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3000	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	1125000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1375000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	6066000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	7166000	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10190433	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9341002	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9842765	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8951035	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	94111000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	92987000	usd
CY2023Q2	vrme	Treasury Stock Share TreasuryStockShare	347668	shares
CY2022Q4	vrme	Treasury Stock Share TreasuryStockShare	389967	shares
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	792000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	949000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80921000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-78459000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-50000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	12358000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13586000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18424000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20752000	usd
CY2023Q2	us-gaap	Revenues Revenues	5335000	usd
CY2022Q2	us-gaap	Revenues Revenues	4497000	usd
	us-gaap	Revenues Revenues	10996000	usd
	us-gaap	Revenues Revenues	4658000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	3515000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	2812000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	7422000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2850000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1820000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	1685000	usd
	us-gaap	Gross Profit GrossProfit	3574000	usd
	us-gaap	Gross Profit GrossProfit	1808000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2342000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2858000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	3007000	usd
	us-gaap	Operating Expenses OperatingExpenses	6116000	usd
	us-gaap	Operating Expenses OperatingExpenses	4780000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1038000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1322000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2542000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2972000	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-46000	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-23000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-88000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-22000	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	30000	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-246000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	6000	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-10964000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-10964000	usd
CY2023Q2	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	172000	usd
	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	172000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	156000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11233000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	80000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10977000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-882000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-12555000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2462000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13949000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.50
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.78
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.50
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.78
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9765452	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8387662	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9614183	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7851463	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9765452	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8387662	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9614183	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7851463	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-882000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-12555000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2462000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13949000	usd
CY2023Q2	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap	2000	usd
	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap	1000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	46000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	48000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-926000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12555000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2509000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13949000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2462000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13949000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	13000	usd
	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	41000	usd
	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	92000	usd
	vrme	Gain Or Loss On Change In Fair Value Of Contingent Consideration GainOrLossOnChangeInFairValueOfContingentConsideration	-172000	usd
	vrme	Fair Value Of Restricted Stock Awards And Restricted Stock Units Issued In Exchange For Services FairValueOfRestrictedStockAwardsAndRestrictedStockUnitsIssuedInExchangeForServices	-560000	usd
	vrme	Fair Value Of Restricted Stock Awards And Restricted Stock Units Issued In Exchange For Services FairValueOfRestrictedStockAwardsAndRestrictedStockUnitsIssuedInExchangeForServices	-650000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-10000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	34000	usd
	vrme	Unrealized Loss Gain On Equity Investment UnrealizedLossGainOnEquityInvestment	-2000	usd
	vrme	Unrealized Loss Gain On Equity Investment UnrealizedLossGainOnEquityInvestment	6000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-10964000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	540000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	243000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3156000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	619000	usd
	vrme	Oprating Unbilled Revenue OpratingUnbilledRevenue	451000	usd
	vrme	Oprating Unbilled Revenue OpratingUnbilledRevenue	-622000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-34000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-46000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	77000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2709000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	693000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-463000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2625000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	42000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	25000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	363000	usd
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	7500000	usd
	vrme	Deferred Implementation Costs DeferredImplementationCosts	56000	usd
	vrme	Deferred Implementation Costs DeferredImplementationCosts	106000	usd
	us-gaap	Payments For Software PaymentsForSoftware	373000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-858000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7631000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4552000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	800000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	71000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	67000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	34000	usd
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	10000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	250000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	608000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4585000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-714000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5671000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3411000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9422000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2697000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3751000	usd
	us-gaap	Interest Paid Net InterestPaidNet	68000	usd
	vrme	Noncash Change In Fair Value Of Interest Rate Swap NoncashChangeInFairValueOfInterestRateSwap	1000	usd
	vrme	Initial Recognition Of Rightofuse Asset And Lease Liability During Period InitialRecognitionOfRightofuseAssetAndLeaseLiabilityDuringPeriod	552000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	20183000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	31000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	274000	usd
CY2022Q2	vrme	Stock Purchase Plan StockPurchasePlan	35000	usd
CY2022Q2	vrme	Common Stock Issued In Relation To Private Placement CommonStockIssuedInRelationToPrivatePlacement	4552000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	96000	usd
CY2022Q2	vrme	Common Stock Issued In Relation To Acquisition CommonStockIssuedInRelationToAcquisition	974000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-12555000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13590000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12962000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	146000	usd
CY2023Q2	vrme	Restricted Stock Units Net Of Shares Withheld For Employee Tax RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax	148000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	28000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-44000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-882000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	12358000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	21167000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	139000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	477000	usd
	vrme	Stock Purchase Plan StockPurchasePlan	67000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	67000	usd
	vrme	Common Stock Issued In Relation To Private Placement CommonStockIssuedInRelationToPrivatePlacement	4552000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	96000	usd
	vrme	Common Stock Issued In Relation To Acquisition CommonStockIssuedInRelationToAcquisition	974000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13949000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13590000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13586000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	147000	usd
	vrme	Restricted Stock Units Net Of Shares Withheld For Employee Tax RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax	410000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	109000	usd
	vrme	Common Stock Issued In Relation To Acquisition CommonStockIssuedInRelationToAcquisition	625000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	10000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-47000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2462000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	12358000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84E_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zlZXlxAfTlH2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i><span style="text-decoration: underline"><span id="xdx_866_zGBKFRi5Skj">Reclassifications</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify">Certain amounts presented for the three and six months ended June 30, 2022, reflect reclassifications made to conform to the presentation in our current reporting period. These reclassifications had no effect on the previously reported net loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_843_eus-gaap--UseOfEstimates_zYzBSedqg8se" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_86D_z1yzpMyYoCs2">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7108000	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7108000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5596000	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5596000	shares
CY2023Q2	vrme	Equity Investments Fair Value EquityInvestmentsFairValue	30000	usd
	vrme	Equity Investments Fair Value EquityInvestmentsFairValue	2000	usd
CY2023Q2	vrme	Equity Investments Fair Value1 EquityInvestmentsFairValue1	98000	usd
CY2022Q4	vrme	Equity Investments Fair Value1 EquityInvestmentsFairValue1	100000	usd
CY2023Q2	us-gaap	Revenues Revenues	5335000	usd
CY2022Q2	us-gaap	Revenues Revenues	4497000	usd
	us-gaap	Revenues Revenues	10996000	usd
	us-gaap	Revenues Revenues	4658000	usd
CY2023Q1	vrme	Business Combination Consideration Transferred BusinessCombinationConsiderationTransferred	360000	usd
CY2023Q1	vrme	Earnout Consideration EarnoutConsideration	1100000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	122000	usd
CY2023Q1	vrme	Business Combination Long Term Contingent Consideration BusinessCombinationLongTermContingentConsideration	831000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	3988000	usd
	us-gaap	Acquisition Costs AcquisitionCosts	1383000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-33000	usd
CY2023Q2	us-gaap	Goodwill Gross GoodwillGross	5338000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8523000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1533000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6990000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7473000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1061000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6412000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	495000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	197000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	534000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1069000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1044000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1040000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1005000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2298000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6990000	usd
CY2023Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	147000	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	148000	usd
CY2022Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	34000	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	173000	usd
CY2023Q2	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	149000	usd
	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	412000	usd
CY2022Q2	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	274000	usd
	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	477000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	19000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	41000	usd
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	347668	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	389967	shares
CY2023Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	792000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	949000	usd
CY2023Q1	vrme	Nonqualified Stock Purchase Plan NonqualifiedStockPurchasePlan	57245	shares
CY2023Q1	vrme	Nonqualified Stock Purchase Exercise Price NonqualifiedStockPurchaseExercisePrice	1.19
CY2022Q1	vrme	Nonqualified Stock Purchase Plan NonqualifiedStockPurchasePlan	25000	shares
CY2022Q1	vrme	Nonqualified Stock Purchase Exercise Price NonqualifiedStockPurchaseExercisePrice	2.69
CY2022Q3	us-gaap	Accelerated Share Repurchases Adjustment To Recorded Amount AcceleratedShareRepurchasesAdjustmentToRecordedAmount	1500000	usd
CY2023Q2	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	6201	shares
CY2023Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	10000	usd
CY2023Q2	vrme	Unrecognized Compensation Cost Outstanding UnrecognizedCompensationCostOutstanding	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	5103455	shares
CY2022Q4	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	4.34
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations	474869	shares
	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice	6.34
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	4628586	shares
CY2023Q2	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	4.13
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y9M18D
CY2023Q2	vrme	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	4628586	shares
CY2023Q2	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice	4.13
	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercisable Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableWeightedAverageRemainingContractualTerms	P2Y9M18D
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	500000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	1100000	usd
	vrme	Principal Outstanding PrincipalOutstanding	250000	usd
CY2023Q2	us-gaap	Line Of Credit LineOfCredit	800000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1958000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.07602	pure
CY2023Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	2000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	3000	usd
CY2023Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	701000	usd
	vrme	Property Plant And Equipment Estimated Useful Lives1 PropertyPlantAndEquipmentEstimatedUsefulLives1	P15Y
CY2023Q1	us-gaap	Goodwill Goodwill	1383000	usd
CY2023Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	2000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	3000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	48000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	21000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	85000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	21000	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	9000	usd
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	18000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	7000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	57000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	24000	usd
	us-gaap	Lease Cost LeaseCost	103000	usd
	us-gaap	Lease Cost LeaseCost	28000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	554000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	469000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	174000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	389000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	563000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	474000	usd
CY2023Q2	vrme	Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities	82000	usd
CY2022Q4	vrme	Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities	80000	usd
CY2022Q4	vrme	Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities	552000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.064	pure
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	94000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	189000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	193000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	139000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	45000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	660000	usd
CY2023Q2	us-gaap	Receivable With Imputed Interest Net Amount ReceivableWithImputedInterestNetAmount	97000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	563000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	174000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	389000	usd
CY2023Q2	us-gaap	Revenues Revenues	5335000	usd
CY2022Q2	us-gaap	Revenues Revenues	4497000	usd
	us-gaap	Revenues Revenues	10996000	usd
	us-gaap	Revenues Revenues	4658000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1820000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	1685000	usd
	us-gaap	Gross Profit GrossProfit	3574000	usd
	us-gaap	Gross Profit GrossProfit	1808000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2342000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2535000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5098000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4000000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	506000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	447000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1000000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	746000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1038000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1322000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2542000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2972000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	156000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11233000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	80000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10977000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-882000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-12555000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2462000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13949000	usd

Files In Submission

Name	View Source	Status
0001214659-23-011000-index-headers.html	Edgar Link	pending
0001214659-23-011000-index.html	Edgar Link	pending
0001214659-23-011000.txt	Edgar Link	pending
0001214659-23-011000-xbrl.zip	Edgar Link	pending
ex10_2.htm	Edgar Link	pending
ex10_3.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
j8323010q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
j8323010q_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vrme-20230630.xsd	Edgar Link	pending
vrme-20230630_def.xml	Edgar Link	unprocessable
vrme-20230630_lab.xml	Edgar Link	unprocessable
vrme-20230630_cal.xml	Edgar Link	unprocessable
vrme-20230630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VRME
VerifyMe Inc Stock $vrme

2023 Q3 Form 10-Q Financial Statement

#000121465923011000 Filed on August 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRME VerifyMe Inc Stock $vrme

2023 Q3 Form 10-Q Financial Statement

#000121465923011000 Filed on August 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRME
VerifyMe Inc Stock $vrme